drugset / Trial / NCT02058212

Use of Antioxidant in Endometriotic Women to Improve Intracytoplasmic Sperm Injection (ICSI)

NCT02058212

Phase 2 Completed 50 enrolled Cairo University
RandomizedParallel-groupSingle-blindSupportive care

Summary

ROS plays an essential role in the pathogenesis of many reproductive processes. High follicular fluid ROS levels are associated with negative IVF outcomes. is plasma level of reactive oxygen species is affected by antioxidant treatment in endometriotic women?

Timeline

Start
2013-03
Primary completion
2013-10
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Selenium Other / unclassified
Comparator Vitamin C Other / unclassified 1000 mg
Comparator Vitamin E Other / unclassified 400 mg
Comparator Zinc Sulfate Unknown

Indications